Follow
Dr. Ghulam Hassan Dar (Gulzar)
Dr. Ghulam Hassan Dar (Gulzar)
Assitant Professor
Verified email at paediatrics.ox.ac.uk
Title
Cited by
Cited by
Year
GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain
GH Dar, CC Mendes, WL Kuan, AA Speciale, M Conceição, A Görgens, ...
Nature communications 12 (1), 6666, 2021
552021
Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer
R Kotcherlakota, DJ Srinivasan, S Mukherjee, MM Haroon, GH Dar, ...
Journal of materials chemistry B 5 (34), 7082-7098, 2017
452017
A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain
MM Haroon, GH Dar, D Jeyalakshmi, U Venkatraman, K Saba, ...
Journal of Controlled Release 228, 120-131, 2016
342016
Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD)
RR Banala, SK Vemuri, GH Dar, V Palanisamy, M Penkulinti, MV Surekha, ...
The Spine Journal 19 (5), 896-904, 2019
302019
Systemic delivery of stable siRNA-encapsulating lipid vesicles: optimization, biodistribution and tumor suppression.
MR Ghulam Hassan Dar, Vijaya Gopa
Molecular Pharmaceutics 12, 610-20, 2015
222015
Conformation-dependent binding and tumor-targeted delivery of siRNA by a designed TRBP2: Affibody fusion protein
GH Dar, V Gopal, M Rao
Nanomedicine: Nanotechnology, Biology and Medicine 11 (6), 1455-1466, 2015
192015
Targeted liposomes to deliver DNA to cells expressing 5-HT receptors
V Gopal, J Xavier, GH Dar, M Jafurulla, A Chattopadhyay, NM Rao
International journal of pharmaceutics 419 (1-2), 347-354, 2011
182011
Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
I Mumtaz, MO Ayaz, MS Khan, U Manzoor, MA Ganayee, AQ Bhat, ...
Frontiers in Aging Neuroscience 14, 977411, 2022
62022
Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease
GH Dar, R Badierah, EG Nathan, MA Bhat, AH Dar, EM Redwan
Frontiers in Aging Neuroscience 14, 967231, 2022
52022
GAPDH controls extracellular vesicle biogenesis and enhances therapeutic potential of EVs in silencing the Huntingtin gene in mice via siRNA delivery
GH Dar, CC Mendes, WL Kuan, M Conceição, S El-Andaloussi, I Mager, ...
bioRxiv, 2020.01. 09.899880, 2020
52020
Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain
GH Dar, CC Mendes, WL Kuan, AA Speciale, M Conceição, A Görgens, ...
Nature Communications 12, 2021
12021
Ibtisam Mumtaz1, Mir Owais Ayaz2, 3, Mohamad Sultan Khan4, Umar Manzoor5, Mohd Azhardin Ganayee1, 6, Aadil Qadir Bhat2, 3, Ghulam Hassan Dar7, Badrah S. Alghamdi8, 9, Anwar M …
I Mumtaz, MO Ayaz, MS Khan, U Manzoor, MA Ganayee, AQ Bhat, ...
The alzheimer’s disease challenge, volume II 16648714, 161, 2023
2023
An extracellular vesicle
GH Dar, M Wood, RA Baker, K Wei-Li
US Patent App. 17/772,526, 2022
2022
Recombinant protein-based method for the delivery of silencer RNA to target the brain
G Vijaya, GH Dar
US Patent 10,640,539, 2020
2020
Targeted Delivery of Short Interfering RNA by Human TAR RNA-Binding Protein-Affibody Chimera
GH Dar, E Nathan, NM Rao, V Gopal
MOLECULAR THERAPY 21, S62-S62, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–15